Cheshire, CT, United States of America

Vilen Kosover

This inventor holds 2 USPTO granted patents and 1 published patent application and 5 EPO patents. Top assignee: Uniroyal Chemical Company, Inc.. Active years: 1998-2001.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1998-2001

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vilen Kosover: Innovator in Polymer Chemistry

Introduction

Vilen Kosover is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of polymer chemistry, holding a total of 2 patents. His work focuses on methods to inhibit the polymerization of ethylenically unsaturated monomers, showcasing his expertise in chemical innovation.

Latest Patents

Kosover's latest patents include a method for inhibiting the premature polymerization of ethylenically unsaturated monomers. This method involves adding an effective amount of an inhibitor with a specific structural formula. Additionally, he has developed substituted tetrahydropyrimidine derivatives, which have various applications in the chemical industry.

Career Highlights

Throughout his career, Vilen Kosover has worked with prominent companies such as Uniroyal Chemical Company, Inc. and Chemtura Corporation. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in polymer chemistry.

Collaborations

Kosover has collaborated with several professionals in his field, including Brigitte Benage and Angela M Edwards. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Vilen Kosover's contributions to polymer chemistry through his patents and collaborations highlight his role as an influential inventor. His innovative methods continue to shape the industry and inspire future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…